Advances in antiretroviral, immune-based, and gene therapy for HIV infection in mothers and infants. Implications for future use in developing countries.
Rubinstein
A
A
Department of Pediatrics, Microbiology, and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461, USA. rubinste@aecom.yu.edu
D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control / Q000628:therapy; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D003906:Developing Countries; D005260:Female; D015316:Genetic Therapy; D015658:HIV Infections / Q000517:prevention & control* / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy; D007223:Infant; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control / Q000628:therapy
D019380:Anti-HIV Agents